Production, purification and titration of a lentivirus-based vector for gene delivery purposes

被引:52
|
作者
Nasri, Masoud [1 ]
Karimi, Ali [2 ]
Farsani, Mehdi Allahbakhshian [3 ]
机构
[1] Tarbiat Modares Univ, Med Biotechnol Dept, Fac Med Sci, Tehran, Iran
[2] Shahre Kord Univ Med Sci, Med Plant Res Ctr, Shahrekord, Iran
[3] Shahid Beheshti Univ Med Sci, Fac Appl Med, Dept Hematol & Blood Banking, Tehran, Iran
关键词
Lentivirus-based vector; Transfection; Transduction; HIGH-TITER; NONDIVIDING CELLS; TRANSDUCTION; CYTOTOXICITY; GLYCOPROTEIN; PROTEIN;
D O I
10.1007/s10616-013-9652-5
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Viral vectors are valuable tools to deliver genetic materials into cells. Vectors derived from human immunodeficiency virus type 1 are being widely used for gene delivery, mainly because they are able to transduce both dividing and non-dividing cells which leads to stable and long term gene expression. In addition, these types of vectors are safe, with low toxicity, high stability and cell type specificity. Therefore, this work was aimed to produce lentivirus-based vector using a three-plasmid system. To produce this system, the eGFP marker gene was cloned into the plasmid pWPXLd. Subsequently, this vector plasmid, along with packaging plasmids, psPAX2 and envelope plasmid, pMD2.G, was co-transfected into packaging cell line (293T) using calcium phosphate method. 48 h post transfection, the constructed viral vector was harvested, purified and concentrated and stored at -80 A degrees C for next experiments. The titration of the vector was carried out, using ELISA, flowcytometry, and fluorescent microscopy. Finally, transduction of HEK-293T, CHO, HepG2, MCF-7, MEFs and Jurkat cell lines was carried out with indicated cell numbers and multiplicities of infections of the vector in the presence of polybrene. Using this system, high titer lentivirus at titers of up to 2 x 10(8) transducing units/ml (TU/ml) was successfully generated and its transduction efficacy was improved by seven to over 20-fold in various cell types. We demonstrate the applicability of this vector for the efficient transduction of dividing and non-dividing cells, including HEK-293T, CHO, HepG2, MCF-7, MEFs and Jurkat cell line. Transduction efficiency yielded titers of (6.3 +/- A 1.2) 10(5) TU/ml. Furthermore, lentivirus transferred transgene was expressed at high level in the target cells and expression was followed until 90 days after transduction. Thus, the vector generated in this work, might be able to deliver the transgene into a wide range of mammalian cells.
引用
收藏
页码:1031 / 1038
页数:8
相关论文
共 50 条
  • [31] Gene Therapy Cargoes Based on Viral Vector Delivery
    Lundstrom, Kenneth
    CURRENT GENE THERAPY, 2023, 23 (02) : 111 - 134
  • [32] Cytokine production in motor neurons by poliovirus replicon vector gene delivery
    Bledsoe, AW
    Jackson, CA
    McPherson, S
    Morrow, CD
    NATURE BIOTECHNOLOGY, 2000, 18 (09) : 964 - 969
  • [33] Cytokine production in motor neurons by poliovirus replicon vector gene delivery
    Andrea W. Bledsoe
    Cheryl A. Jackson
    Sylvia McPherson
    Casey D. Morrow
    Nature Biotechnology, 2000, 18 : 964 - 969
  • [34] Dendritic Poly(ether imine) Based Gene Delivery Vector
    Thankappan, Ullas Padinjaremattathil
    Madhusudana, Shampur Narayan
    Desai, Anita
    Jayamurugan, Govindasamy
    Rajesh, Yamajala B. R. D.
    Jayaraman, Narayanaswamy
    BIOCONJUGATE CHEMISTRY, 2011, 22 (02) : 115 - 119
  • [35] Editorial: Vector-based gene delivery in cancer immunotherapy
    Cheng, Ning
    Yang, Xiaoyue
    Chen, Dan
    Xu, Chun
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [36] Cell-based vector delivery for cancer gene therapy
    Chester, JD
    Diaz, RM
    Ruchatz, A
    Chong, H
    Clackson, T
    Cosset, FL
    Alvarez-Vallina, L
    Russell, SJ
    Harrington, KJ
    Vile, RG
    BRITISH JOURNAL OF CANCER, 2001, 85 : 24 - 24
  • [37] Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes
    Tasyurek, H.
    Eksi, Y. E.
    Sanlioglu, A. D.
    Balci, M. K.
    Sanlioglu, S.
    HUMAN GENE THERAPY, 2014, 25 (11) : A86 - A86
  • [38] A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery
    Srinivasakumar, N
    Schuening, FG
    JOURNAL OF VIROLOGY, 1999, 73 (11) : 9589 - 9598
  • [39] BRaf signaling principles unveiled by large-scale human mutation analysis with a rapid lentivirus-based gene replacement method (vol 31, pg 537, 2017)
    Lim, Chae-Seok
    Kang, Xi
    Mirabella, Vincent
    Zhang, Huaye
    Bu, Qian
    Araki, Yoichi
    Hoang, Elizabeth T.
    Wang, Shiqiang
    Shen, Ying
    Choi, Sukwoo
    Kaang, Bong-Kiun
    Chang, Qiang
    Pang, Zhiping P.
    Huganir, Richard L.
    Zhu, J. Julius
    GENES & DEVELOPMENT, 2017, 31 (08) : 846 - 846
  • [40] Sphingosine-Based Liposome as DNA Vector for Intramuscular Gene Delivery
    Karin Baraldo
    Nicolas Leforestier
    Michel Bureau
    Nathalie Mignet
    Daniel Scherman
    Pharmaceutical Research, 2002, 19 : 1144 - 1149